Opiant Pharmaceuticals, Inc.

WELLS FARGO & COMPANY/MN

Report date

12/31/2022

Quarter

2022 Q4

Filed

2/13/2023

Shares

136,814

Value ($000)

2,775

Weight

0.0%

2019 Q4 - 2022 Q4 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q4	2/13/2023	2,775	0.0%	136,814	12/31/2022
2022 Q3	11/14/2022	2,205	0.0%	205,117	9/30/2022
2022 Q2	8/12/2022	2,436	0.0%	203,231	6/30/2022
2022 Q1	5/16/2022	4,396	0.0%	205,226	3/31/2022
2021 Q4	2/14/2022	7,543	0.0%	224,297	12/31/2021
2021 Q3	11/15/2021	6,371	0.0%	247,492	9/30/2021
2021 Q2	8/16/2021	3,356	0.0%	251,007	6/30/2021
2021 Q1	5/13/2021	2,656	0.0%	250,082	3/31/2021
2020 Q4	2/9/2021	2,025	0.0%	252,205	12/31/2020
2020 Q3	11/5/2020	1,548	0.0%	206,950	9/30/2020
2020 Q2	8/13/2020	1,007	0.0%	111,536	6/30/2020
2020 Q1	5/14/2020	36	0.0%	3,821	3/31/2020
2019 Q4	2/14/2020	55	0.0%	3,800	12/31/2019